产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 10mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 | |||
| 250mg | 95% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 10mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 | |||
| 250mg | 95% | 询价 |
CAS No. |
2041075-86-7 |
|---|---|
中文名称 |
(1R,2R)-2-[4-(5-甲基-1H-吡唑-3-基)苯甲酰基]-N-(4-氧代-4,5,6,7-四氢吡唑并[1,5-a]吡嗪-3-基)环己烷-1-甲酰胺 |
英文名称 |
(1R,2R)-2-(4-(5-Methyl-1H-pyrazol-3-yl)benzoyl)-N-(4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl)cyclohexane-1-carboxamide |
别名 |
Cyclohexanecarboxamide, 2-[4-(5-methyl-1H-pyrazol-3-yl)benzoyl]-N-(4,5,6,7-tetrahydro-4-oxopyrazolo[1,5-a]pyrazin-3-yl)-, (1R,2R)-;Atuliflapon;Inhibitor,inhibit,FLAP,AZD-5718,AZD 5718,artery,Atuliflapon,disease,Coronary,5-LO activating protein;(1R,2R)-2-[4-(5-methyl-1H-pyrazol-3-yl)benzoyl]-N-{4-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazin-3-yl}cyclohexane-1-carboxamide;Atuliflapon (AZD5718);Atuliflapon, 10 mM in DMSO;(1R,2R)-2-(4-(5-Methyl-1H-pyrazol-3-yl)benzoyl)-N-(4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl)cyclohexane-1-carboxamide |
标准英文名 |
Atuliflapon |
分子式 |
C24H26N6O3 |
分子量 |
446.51 |
精确分子量 |
446.21 |
SMILES |
O=C([C@H]1[C@@H](CCCC1)C(C2=CC=C(C3=NNC(C)=C3)C=C2)=O)NC4=C5N(CCNC5=O)N=C4 |
标准SMILES |
CC1=CC(=NN1)C1C=CC(=CC=1)C(=O)[C@@H]1CCCC[C@H]1C(=O)NC1C=NN2CCNC(=O)C2=1 |
性状 |
White to off-white powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
ROTWSDMXHVGAHZ-QZTJIDSGSA-N |
危险类别(旧) |
H302,H315,H319 |
存储要求 |
Sealed in dry, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|